Walleye Capital’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-86,641
| Closed | -$186K | – | 2800 |
|
|
2024
Q3 | $186K | Sell |
86,641
-199,162
| -70% | -$428K | ﹤0.01% | 1719 |
|
|
2024
Q2 | $1.47M | Buy |
285,803
+867
| +0.3% | +$4.47K | ﹤0.01% | 944 |
|
|
2024
Q1 | $1.52M | Buy |
+284,936
| New | +$1.52M | ﹤0.01% | 862 |
|
|
2022
Q4 | – | Sell |
-12,800
| Closed | -$82K | – | 2700 |
|
|
2022
Q3 | $82K | Buy |
+12,800
| New | +$82K | ﹤0.01% | 1700 |
|
|
2022
Q2 | – | Sell |
-5,609
| Closed | -$67K | – | 2713 |
|
|
2022
Q1 | $67K | Buy |
5,609
+4,509
| +410% | +$53.9K | ﹤0.01% | 1747 |
|
|
2021
Q4 | $36K | Sell |
1,100
-2,223
| -67% | -$72.8K | ﹤0.01% | 1765 |
|
|
2021
Q3 | $149 | Buy |
+3,323
| New | +$149 | ﹤0.01% | 1220 |
|